Inventor · disambiguated record
Yoshiyuki Fukase
Also filed as: FUKASE YOSHIYUKI
19 granted patents·6 pending applications·43 citations·filing 2006–2025
92Inventor score
Files withTAKEDA PHARMACEUTICALS CO11TAKEDA PHARMACEUTICAL4KUROITA TAKANOBU3MEMORIAL SLOAN KETTERING CANCER CENTER2UNIV ROCKEFELLER2
Top patents by PatentIndex Score
25 records- 0191US9365520B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted Jun 14, 2016·9 cites·2 claims
- 0287US9573903B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 21, 2017·5 cites·2 claims
- 0383US10000488B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·3 cites·13 claims
- 0482US10472376B2Amide compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Nov 12, 2019·5 cites·13 claims
- 0579US8466282B2Heterocyclic compound and use thereofKUROITA TAKANOBU·Filed 2009·Granted Jun 18, 2013·3 cites·1 claims
- 0679US7803822B2Triazole derivative and use thereofTAKEDA PHARMACEUTICAL·Filed 2006·Granted Sep 28, 2010·6 cites·10 claims
- 0776US11053262B2Heterocyclic amide compounds having RORyT inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 0876US9156837B2Heterocyclic compoundYAMAMOTO SATOSHI·Filed 2012·Granted Oct 13, 2015·5 cites·12 claims
- 0974US9630924B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Apr 25, 2017·1 cites·2 claims
- 1073US11851449B2Heterocyclic amide compounds having an RORvt inhibitory actionTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Dec 26, 2023·0 cites·11 claims
- 1170US8329691B2Amide compounds and use of the sameIMAEDA YASUHIRO·Filed 2008·Granted Dec 11, 2012·3 cites·12 claims
- 1266US9834520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Dec 5, 2017·1 cites·15 claims
- 1366US9120776B2Condensed heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2012·Granted Sep 1, 2015·1 cites·12 claims
- 1460US9650343B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 16, 2017·0 cites·2 claims
- 1556US10093629B2Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Oct 9, 2018·0 cites·9 claims
- 1654US10053468B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Aug 21, 2018·0 cites·18 claims
- 1753US2016046601A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2015·Application pending·0 cites
- 1852US2025361218A1Agents and methods for treating dysproliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 1951US11964960B2Pyridinone- and pyridazinone-based compounds and uses thereofUNIV CORNELL·Filed 2019·Granted Apr 23, 2024·0 cites·5 claims
- 2051US2023027198A1Inhibitors of enl/af9 yeatsUNIV ROCKEFELLER·Filed 2020·Application pending·0 cites
- 2150US2018319812A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Application pending·0 cites
- 2250US2009227560A1Substituted imidazole compound and use thereofKUROITA TAKANOBU·Filed 2008·Application pending·0 cites
- 2347US12215090B2Agents and methods for treating dysproliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Feb 4, 2025·0 cites·31 claims
- 2446US2009156612A1Substituted imidazole compound and use thereofKUROITA TAKANOBU·Filed 2008·Application pending·0 cites
- 2538US11192893B2Pyrazoloquinazolinone antitumor agentsUNIV ROCKEFELLER·Filed 2018·Granted Dec 7, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Yoshiyuki Fukase files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →